SEC 13F Intelligence

Legal & General Group PLC / ABBV

Legal & General Group PLC’s Abbvie Inc Position

Does Legal & General Group PLC own Abbvie Inc (ABBV)? Yes12.16M shares worth $2.6B (+0.61% of its 13F portfolio) as of Q1 2026, up from 12.13M shares the prior filed quarter.

Position Value
$2.6B
Q1 2026
Shares
12.16M
% of Portfolio
+0.61%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $681MQ4 ’18Q1 ’19: $723MQ2 ’19: $644MQ3 ’19: $678MQ4 ’19: $810MQ4 ’19Q1 ’20: $716MQ2 ’20: $1.1BQ3 ’20: $948MQ4 ’20: $1.2BQ4 ’20Q1 ’21: $1.2BQ2 ’21: $1.3BQ3 ’21: $1.3BQ4 ’21: $1.5BQ4 ’21Q1 ’22: $2.0BQ2 ’22: $1.9BQ3 ’22: $1.6BQ4 ’22: $1.9BQ4 ’22Q1 ’23: $1.9BQ2 ’23: $1.7BQ3 ’23: $1.8BQ4 ’23: $2.4BQ4 ’23Q1 ’24: $2.8BQ2 ’24: $2.6BQ3 ’24: $3.0BQ4 ’24: $2.4BQ4 ’24Q1 ’25: $1.9BQ2 ’25: $2.1BQ3 ’25: $2.8BQ4 ’25: $2.8BQ4 ’25Q1 ’26: $2.6Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202612.16M$2.6B+0.61%
Q4 202512.13M$2.8B+0.61%
Q3 202512.00M$2.8B+0.62%
Q2 202511.51M$2.1B+0.53%
Q1 202512.28M$1.9B+0.59%
Q4 202412.02M$2.4B+0.62%
Q3 202415.18M$3.0B+0.62%
Q2 202415.28M$2.6B+0.59%
Q1 202415.14M$2.8B+0.65%
Q4 202315.21M$2.4B+0.60%
Q3 202312.09M$1.8B+0.63%
Q2 202312.63M$1.7B+0.55%
Q1 202311.89M$1.9B+0.68%
Q4 202211.74M$1.9B+0.73%
Q3 202212.27M$1.6B+0.64%
Q2 202212.53M$1.9B+0.68%
Q1 202212.05M$2.0B+0.59%
Q4 202111.27M$1.5B+0.46%
Q3 202111.64M$1.3B+0.41%
Q2 202111.18M$1.3B+0.42%
Q1 202110.99M$1.2B+0.44%
Q4 202011.28M$1.2B+0.47%
Q3 202010.83M$948M+0.42%
Q2 202011.15M$1.1B+0.53%
Q1 20209.39M$716M+0.42%
Q4 20199.15M$810M+0.39%
Q3 20198.96M$678M+0.36%
Q2 20198.85M$644M+0.35%
Q1 20198.97M$723M+0.41%
Q4 20187.39M$681M+0.53%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Legal & General Group PLC’s full portfolio or all institutional holders of ABBV.